This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
120511-88-8
Anastrozole impurity E
C15H18N2O
MW = 242.3
2-[3-(1-Cyano-1-methylethyl)-5-(hydroxymethyl)phenyl]-2-methylpropanenitrile
Technical Data
| C15H18N2O | |
|---|---|
| MW = 242.3 | |
| White to Off White Solid | |
| Melting point = 150-160℃ | |
| Density = 1.084 |
Storage Shipping
| P202 - Do not handle until all safety precautions have been read and understood | |
|---|---|
| H302 + H312 + H332 - Harmful if swallowed, in contact with skin or if inhaled | |
| H303 - May be harmful if swallowed | |
| Store at 2-8°C, ship at ambient temperature |
Description
Anastrozole impurity E; CAS 120511-88-8; (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile) is an impurity of Anastrazole, a medication used to treat hormone receptor-positive breast cancer.